Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-24

Clinical Trial Update: TBI Dose De-escalation for Fanconi Anemia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on dose de-escalation of total body irradiation (TBI) for Fanconi Anemia, completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Fanconi Anemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-11-24